TAK-661
TAK-661 is a inhibitor of eosinophil chemotaxis. TAK-661 significantly reduces the bronchoconstriction during the late phase, along with the inhibition of eosinophilia in bronchoalveolar lavage (BAL) and the eosinophil infiltration into the airway wall[1].
Product Specifications
CAS Number
175215-34-6
UNSPSC
12352005
Target
CCR
Type
Reference compound
Related Pathways
GPCR/G Protein; Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/tak-661.html
Smiles
O=S(N)(CC(C)(COC1=NN2N=CN=C2C=C1C(C)C)C)=O
Molecular Formula
C13H21N5O3S
Molecular Weight
327.40
References & Citations
[1]K Fujimoto, et al. Effects of an eosinophil chemotaxis inhibitor, TAK-661, on antigen-induced asthmatic responses in allergic sheep. Lung. 2002;180 (3) :161-72.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC041926-100 1x 100 µL
SOX9 / SRY-box 9 (PCRP-SOX9-1E5), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNUB2343-100 1x 100 µL
CD9 (TSPAN29) (Motility-Related Protein-1) (CD9/2343), 0.2mg/mL
Sign In for Pricing
View Details 
475-AAT 5 mg
Texas Red-X, succinimidyl ester *Mixed isomers* *CAS 216972-99-5*
Sign In for Pricing
View Details 
